Nephrology & urology
Kidney & urinary clinical trials
Kidney disease and conditions of the bladder and urinary tract. We’re tracking 4,387 recruiting studies in this area right now.
By phase
- Not applicable2,710
- Phase 2569
- Phase 1367
- Phase 3266
- Phase 1/Phase 2227
- Phase 4192
- Phase 2/Phase 356
Top conditions
- Prostate Cancer645
- Bladder Cancer186
- Acute Kidney Injury133
- Chronic Kidney Diseases123
- Chronic Kidney Disease107
- Breast Cancer105
- Renal Cell Carcinoma80
- Urinary Incontinence60
- Kidney Cancer59
- Colorectal Cancer58
- Ovarian Cancer57
- Lung Cancer51
- Cancer48
- Lupus Nephritis48
- Melanoma48
- Metastatic Prostate Cancer47
- Head and Neck Cancer46
- Prostate Cancer (Adenocarcinoma)45
Leading sponsors
- Mayo Clinic64
- National Cancer Institute (NCI)48
- Peking University First Hospital39
- M.D. Anderson Cancer Center36
- Novartis Pharmaceuticals34
- Chinese University of Hong Kong33
- AstraZeneca29
- IRCCS Azienda Ospedaliero-Universitaria di Bologna29
- Memorial Sloan Kettering Cancer Center29
- Assistance Publique - Hôpitaux de Paris27
Where studies are running
- California359
- Arizona109
- Alabama107
- Florida95
- New York95
- Maryland91
- Texas91
- Massachusetts89
- Illinois66
- Minnesota50
Recruiting studies4,387 total
- NCT07650240RecruitingPhase 2
PSMA Therapy and Hormone Treatment for Early-Stage Prostate Cancer Spread
This trial tests a combination of two treatments for men with prostate cancer that has spread to a small number of sites: a radioactive injection (177Lu-PSMA-617) that targets cancer cells, plus hormone-blocking medication. The goal is to control the cancer and delay progression.
Rochester, MinnesotaAges 18 years+ - NCT07649681Recruiting
AI nutrition help for taste changes from cancer treatment
This study tests whether an AI-powered nutrition program can help people with taste changes caused by cancer therapy. You'll get personalized recipe suggestions and nutrition advice through an online portal to help you eat better during treatment.
Augsburg, BavariaAges 18 years+ - NCT07650968RecruitingPhase 4
Prostate Medication Adjustment After Sudden Inability to Urinate
This trial tests whether increasing your prostate medication (tamsulosin) or switching to a different medication (silodosin) helps you urinate normally again after a sudden blockage caused by an enlarged prostate. The goal is to help you avoid long-term catheter use.
Banī Suwayf, Beni Suweif GovernorateAges 50 years+ - NCT07650955Recruiting
Two surgery approaches for enlarged veins affecting fertility
This trial compares two different surgical techniques to treat bilateral varicocele (enlarged veins in the scrotum) that may be causing infertility. The goal is to see which approach works better and causes fewer complications.
Banī Suwayf, Beni Suweif GovernorateAges 18–45 - NCT06027892Recruiting
Comparing two shorter radiation treatments for prostate cancer
This trial tests if a two-session radiation treatment works as well as a five-session one for men with low-risk or favorable intermediate-risk prostate cancer. It aims to reduce the number of visits while maintaining effectiveness.
Petah Tikva, IsraelAges 18 years+ - NCT07641049RecruitingPhase 1
CAR-NK Cell Therapy for Advanced Prostate Cancer
This trial tests a new type of immune cell therapy (CAR-NK cells) designed to target and fight advanced prostate cancer that has stopped responding to hormone treatments. The cells are engineered to recognize and attack cancer cells that have specific markers (PSMA and PSCA) on their surface.
Shenzhen, GuangdongAges 18 years+ - NCT07645235RecruitingPhase 1
Gepotidacin in Breast Milk of Lactating Women
This study measures how much of an antibiotic called gepotidacin passes into breast milk. Researchers will give healthy breastfeeding women a single dose and collect milk samples to understand if it's safe for nursing infants.
Las Vegas, NevadaAges 18–50 - NCT07641426RecruitingPhase 1/Phase 2
CID-103 Treatment for Kidney Transplant Rejection
This study tests an experimental drug called CID-103 to treat antibody-mediated rejection (ABMR), a type of immune response that damages transplanted kidneys. The drug targets immune cells that attack the transplant, and researchers hope it may help preserve kidney function and prevent transplant failure.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07645872Recruiting
Collecting Data From Prostate Cancer Patients Treated With Focal One
This study gathers information from patients who are being treated for prostate cancer using a machine called Focal One, which uses focused ultrasound to target cancer cells. The goal is to collect real-world data about how the treatment works and its effects.
Aix-en-ProvenceAges Any age - NCT05346393Recruiting
TIPS procedure for kidney failure in people with cirrhosis
This trial studies whether a liver procedure called TIPS can help people with cirrhosis who develop sudden kidney failure (HRS-AKI). It aims to improve kidney function and overall outcomes, but participation depends on several safety checks.
AachenAges 18–80 - NCT04787042RecruitingPhase 1/Phase 2
Safety and early benefits of ST-067 for advanced solid tumors
This early-stage trial tests ST-067 to see if it is safe and whether it may shrink advanced cancers. It also looks at how the drug moves through the body and affects the immune system.
Scottsdale, ArizonaAges 18 years+ - NCT05656573RecruitingPhase 1
Study of PSMA-targeted CAR T for advanced prostate cancer
This Phase 1 study tests a type of immune cell treatment (CAR T) made to recognize PSMA, a marker on prostate cancer cells. It’s for advanced prostate cancer and aims to find a safe dose and how well the treatment works.
BeijingAges 35–85 - NCT07643415Recruiting
Spinal vs. General Anesthesia for Prostate Surgery
This study compares two types of anesthesia—spinal (numbing the lower body) versus general (putting you to sleep)—for men having prostate surgery to treat benign enlargement. The goal is to see which approach works better and is safer for this procedure.
ÇorumAges 18 years+ - NCT07644598RecruitingPhase 2
Targeted Radiation Therapy for Low to Intermediate Risk Prostate Cancer
This study tests a new radiation treatment approach that uses MRI imaging to target specific tumor areas within the prostate while reducing radiation to healthy tissue. It may help patients with early-stage prostate cancer get effective treatment with fewer side effects.
Washington D.C., District of ColumbiaAges 18 years+ - NCT07639580Enrolling by invitation
Urinary Leaks and Energy in Professional Dancers
This study looks at how urinary incontinence (accidental leakage) and low energy affect professional and student dancers. Researchers want to understand these issues better in people who dance at a high level.
SienaAges 18 years+ - NCT07642063Enrolling by invitation
Comparing surgical techniques for enlarged prostate laser treatment
This trial tests two different surgical approaches using a laser to treat an enlarged prostate. The study compares whether one technique reduces complications and improves outcomes better than the other.
TantaAges 50–80 - NCT07645391Recruiting
Early Detection Program for Men at High Genetic Risk for Prostate Cancer
This study aims to find prostate cancer early in men who have a genetic predisposition (inherited genetic mutations or strong family history) that puts them at higher risk. The goal is to detect it sooner, when treatment may be more effective.
Ann Arbor, MichiganAges 35–70 - NCT07642440Recruiting
Suprapubic Drainage During Bladder Stone Removal Surgery
This trial tests whether a temporary drainage tube placed above the pubic bone during bladder stone removal surgery improves outcomes. You would be considered if you have a large bladder stone (over 2 cm) and are scheduled for minimally invasive surgery to break it up and remove it.
Banī Suwayf, Beni Suweif GovernorateAges 18 years+ - NCT07643597Recruiting
Managing fluid removal in critically ill patients with acute kidney injury
This study looks at how to safely remove excess fluid from patients in the ICU who have sudden kidney failure and are on a special blood-filtering machine (CRRT). Researchers want to understand which patients have trouble tolerating fluid removal and how to prevent complications.
SalvadorAges 18 years+ - NCT07643467RecruitingPhase 4
Fluorescent dye test for kidney function in ICU patients
This trial tests a new fluorescent dye that may help doctors quickly check how well your kidneys are working while you are in the intensive care unit. It could provide a faster, less invasive way to monitor kidney health.
Lexington, KentuckyAges 18–65 - NCT07644273Recruiting
Training program for urinary leakage in young female athletes
This study tests a training program designed to help young female athletes who experience urinary leakage during sports. The program combines exercises and education to see if it can reduce or stop leakage.
Saint-EtienneAges 15–40 - NCT07638306Recruiting
Neck Vein Ultrasound and Kidney Function After Abdominal Surgery
This study uses ultrasound to look at a vein in your neck before and after major abdominal surgery to understand how surgery affects your kidneys. Researchers hope this simple imaging technique might help predict and prevent kidney problems after surgery.
Târgu Mureş, Mureș CountyAges 18 years+ - NCT07645794Enrolling by invitation
MRI Scans to Detect Bone and Muscle Loss in Kidney Disease
This study tests a new MRI imaging method to detect bone loss (osteoporosis) and muscle loss (sarcopenia) in people with chronic kidney disease. The scan may help doctors catch these problems earlier and manage kidney disease better.
Beijing, Beijing MunicipalityAges 18–80 - NCT07642505RecruitingPhase 4
L-Citrulline and Tadalafil for Mild Erectile Dysfunction
This study tests whether two compounds—L-citrulline (a natural amino acid) and tadalafil (a common erectile dysfunction medication)—work well together for men with mild to moderate erectile problems. The goal is to see if this combination safely improves sexual function.
Banī Suwayf, Beni Suweif GovernorateAges 30–70
Common questions
- How many kidney & urinary clinical trials are recruiting?
- Clin2 is tracking 4,387 recruiting nephrology & urology studies from the U.S. registry right now, out of 6,805 we cover in this area in total.
- What does “Kidney & urinary” cover here?
- Kidney disease and conditions of the bladder and urinary tract. We group each study into kidney & urinary based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a kidney & urinary trial near me?
- Use the search to filter kidney & urinary studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
- Cancer
- Brain & nervous system
- Heart & circulation
- Hormones & metabolism
- Mental health
- Digestive system
- Lungs & breathing
- Immune system & allergy
- Women’s health & pregnancy
- Skin
- Blood & lymphatic
- Infections
- Genetic & congenital
- Bones, joints & muscles
- Pain
- Injuries & trauma
- Mouth & dental
- Eyes & vision
- Ear, nose & throat
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.